Flow cytometric characterization of phenotype, DNA indices and p53 gene expression in 55 cases of acute leukemia

Analytical and Quantitative Cytology and Histology

Volumn 24, Issue 3, 2002, Pages 159-165

  Powari, Manish ^a   Varma, Neelam ^a   Varma, Subhash ^a   Marwaha, Ram Kumar ^a   Sandhu, Harpreet ^a   Ganguly, Nirmal Kumar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

DNA; Flow cytometry; Leukemia; P53 genes; Phenotype; S phase fraction

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; MYELOPEROXIDASE; PROTEIN P53; DNA; LEUKOCYTE ANTIGEN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ARTICLE; BONE MARROW BIOPSY; CELL CYCLE S PHASE; CELL LINEAGE; CHILD; DIPLOIDY; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TETRAPLOIDY; UNDIFFERENTIATED CARCINOMA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; CLASSIFICATION; CLINICAL TRIAL; FOLLOW UP; GENETICS; METABOLISM; METHODOLOGY; TUMOR SUPPRESSOR GENE;

ADOLESCENT; AGED; ANTIGENS, CD; CHILD; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GENE EXPRESSION; GENES, P53; HUMAN; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PROTEIN P53; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035987633     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Acute leukemias
2. Morphologic, immunologic and cytogenetic (MIC) working classification of acute lymphoblastic leukemia
3. Morphologic, immunologic and cytogenetic (MIC) working classification of acute myeloid leukemia
4. Proposal for classification of acute leukemias: French-American-British (FAB) Cooperative Group
5. Flow cytometry in diagnosis of acute leukemia
6. Proposal for recognition of minimally differentiated AML (MO)
7. Immunophenotyping in diagnosis of acute leukemia
8. Criteria for diagnosis of AML-M7
9. European Group for Immunological Characterization of Leukemias (EGIL): Proposals for immunological classification of acute leukemia
10. Ploidy of lymphoblasts is the strongest predictor of treatment in B-progenitor cell ALL of childhood: A Pediatric Oncology Group Study
11. On behalf of the MRC Adult Leukemia Working Party: Cytogenetics add independent prognostic information in adults with ALL in MRC trial UKALLXA
12. Hypodiploidy is associated with poor prognosis in childhood ALL
13. Prognostic importance of blast cell DNA content in childhood ALL
14. p53 in haematologic malignancies
15. Analysis of p53 gene mutation in acute myeloid leukemia: The p53 gene mutations associated with a deletion of chromosome 17
16. Mutations of p53 gene in acute myeloid leukemia
17. Treatment of ALL in adults with modified BFM regimen
18. Prognostic significance of DNA index by FCM in ALL
19. Immunologic subtypes of ALL in North India
20. Immunocytochemistry labelling of monoclonal antibodies by APAAP
21. Flow cytometric DNA analysis of hemopoietic and lymphoid malignancies
22. Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia
23. Tumour suppressor gene alteration in adult ALL: Analysis of Rb and p53 gene expression in lymphoblasts of patients with denovo, relapsed or refractory ALL treated in Southwest Oncology Group Study
24. Incidence of potential p53 inactivation in poor outcome childhood ALL at diagnosis
25. Clinical and biological relevance of immunologic marker studies in childhood ALL
26. Hybrid acute leukemia
27. Acute biphenotypic leukemia: Immunophenotypic and cytogenetic analysis
28. Immunophenotypic analysis of acute leukemia
29. Recent advances in FCM: Application to diagnosis of hematologic malignancies
30. Aneuploidy and percentage of S-phase determined by FCM correlate with cell phenotype of childhood acute leukemia
31. Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemia in Hong Kong
32. DNA index of % S-phase cells determination in acute lymphoblastic leukemia of childhood
33. Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on haematologic cell lineages
34. Mutations of p53 gene in human AML
35. Cytogenetics and prognosis in childhood acute lymphoblastic leukemia: Results of MRC UKALLX Medical Research Council Working Party in childhood leukemia
36. p53 expression and poor prognosis in childhood acute lymphoblastic leukemia
37. Clinical significance of detecting p53 protein in Burkitt lymphoma and B-cell acute lymphoblastic leukemia using immunocytochemistry
38. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
39. Correlation between mutations in p53 gene and protein expression in human lymphoma